Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
35.75 USD | -1.24% | +0.96% | +22.98% |
Mar. 07 | Kewaunee Scientific Shares Fall After Company Posts Lower Fiscal Q3 Net Sales | MT |
Mar. 06 | Earnings Flash (KEQU) KEWAUNEE SCIENTIFIC CORPORATION Posts Q3 Revenue $46.8M | MT |
Financials (USD)
Sales 2022 | 169M | Sales 2023 | 219M | Capitalization | 45.99M |
---|---|---|---|---|---|
Net income 2022 | -6M | Net income 2023 | - | EV / Sales 2022 | 0.44 x |
Net Debt 2022 | 34.36M | Net Debt 2023 | 33.62M | EV / Sales 2023 | 0.36 x |
P/E ratio 2022 |
-6.48
x | P/E ratio 2023 |
65
x | Employees | 982 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 74.33% |
1 day | -0.55% | ||
1 week | +1.12% | ||
Current month | +5.23% | ||
1 month | +12.77% | ||
3 months | +23.59% | ||
6 months | +100.00% | ||
Current year | +24.53% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Hull
CEO | Chief Executive Officer | 48 | 15-10-31 |
Donald Gardner
DFI | Director of Finance/CFO | 45 | 19-04-28 |
Mandar Ranade
CTO | Chief Tech/Sci/R&D Officer | 50 | 19-12-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Rhind
CHM | Chairman | 61 | 08-03-31 |
Donald Shaw
BRD | Director/Board Member | 73 | 13-05-31 |
Keith Gehl
BRD | Director/Board Member | 65 | 15-04-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 35.75 | -1.24% | 2 346 |
24-04-24 | 36.2 | -0.55% | 3,550 |
24-04-23 | 36.4 | +2.77% | 11,409 |
24-04-22 | 35.42 | +0.17% | 13,699 |
24-04-19 | 35.36 | -0.14% | 2,974 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+24.53% | 104M | |
+12.97% | 7.5B | |
+2.63% | 2.94B | |
+1.64% | 2.88B | |
+2.15% | 2.02B | |
-10.50% | 1.39B | |
+6.15% | 1.43B | |
-19.24% | 470M | |
-0.29% | 437M | |
-14.05% | 380M |
- Stock Market
- Equities
- KEQU Stock